Principal Investigator[1]
Development and Validation of a Blood-Based Biomarker to Identify Overt and Prodromal Dementia with Lewy Bodies
Reviewed sources document Development and Validation of a Blood-Based Biomarker to Identify Overt and Prodromal Dementia with Lewy Bodies. Explore attributed publications and research affiliations.
Explore researchPrincipal Investigator[1]
Development and Validation of a Blood-Based Biomarker to Identify Overt and Prodromal Dementia with Lewy Bodies[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
3 source claims · Reviewed Sep 9, 2026
Identity: Owen Ross
Principal Investigator: Owen Ross; Co-Investigator: Tanis Ferman
Professional role: Principal Investigator
Principal Investigator: Owen Ross; Co-Investigator: Tanis Ferman
Research interests: Development and Validation of a Blood-Based Biomarker to Identify Overt and Prodromal Dementia with Lewy Bodies
- American Academy of Neurology Brain Foundation. Development and Validation of a Blood-Based Biomarker to Identify Overt and Prodromal Dementia with Lewy Bodies, 01/01/2022-12/31/2024. Principal Investigator: Owen Ross; Co-Investigator: Tanis Ferman